Volume 16, Number 22,
Issue of November 15, 1996
pp. 7336-7346
Copyright ©1996 Society for Neuroscience
Methylmalonyl-CoA Mutase Induction by Cerebral Ischemia and
Neurotoxicity of the Mitochondrial Toxin Methylmalonic Acid
Received June 17, 1996; revised Aug. 26, 1996; accepted Aug. 29, 1996.
Purnima Narasimhan,
Robert Sklar,
Matthew Murrell,
Raymond
A. Swanson, and
Frank R. Sharp
Department of Neurology, University of California, San Francisco,
San Francisco, California 94143, and Department of Veterans Affairs
Medical Center, San Francisco, California 94121
Differential screening of gerbil brain hippocampal cDNA libraries
was used to search for genes expressed in ischemic, but not normal,
brain. The methylmalonyl-CoA mutase (MCM) cDNA was highly expressed
after ischemia and showed a 95% similarity to mouse and 91%
similarity to the human MCM cDNAs. Transient global ischemia induced a
fourfold increase in MCM mRNA on Northern blots from both hippocampus
and whole forebrain. MCM protein exhibited a similar induction on
Western blots of gerbil cerebral cortex 8 and 24 hr after ischemia.
Treatment of primary brain astrocytes with either the branched-chain
amino acid (BCAA) isoleucine or the BCAA metabolite, propionate,
induced MCM mRNA fourfold. Increased concentrations of BCAAs and
odd-chain fatty acids, both of which are metabolized to propionate, may
contribute to inducing the MCM gene during ischemia.
Methylmalonic acid, which is formed from the MCM substrate
methylmalonyl-CoA and which inhibits succinate dehydrogenase (SDH),
produced dose-related cell death when injected into the basal ganglia
of adult rat brain. This neurotoxicity is similar to that of
structurally related mitochondrial SDH inhibitors, malonate and
3-nitropropionic acid. Methylmalonic acid may contribute to neuronal
injury in human conditions in which it accumulates, including MCM
mutations and B12 deficiency. This study shows that
methylmalonyl-CoA mutase is induced by several stresses, including
ischemia, and would serve to decrease the accumulation of an endogenous
cellular mitochondrial inhibitor and neurotoxin, methylmalonic acid.
Key words:
methylmalonic acid;
methylmalonyl-CoA mutase;
branched-chain amino acids;
odd-chain fatty acids;
propionate;
cerebral
ischemia;
stroke;
excitatory amino acids;
vitamin B12;
astrocytes;
3-nitropropionic acid;
succinate dehydrogenase;
malonate;
hypoxia;
mitochondria